Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LAT1 (SLC7A5) is a light subunit of a heterodimeric amino acid transporter that forms a complex with CD98/4F2hc (SLC3A2). This complex facilitates the transport of large neutral amino acids across cell membranes, particularly at the blood-brain barrier, placenta, and in cancer cells. It plays a crucial role in nutrient uptake, cell growth regulation via mTORC1 signaling, and is implicated in various diseases including cancer and neurological disorders. LAT1 is a target for drug delivery and cancer therapy.
Na⁺-, pH-independent antiport/exchange of large neutral amino acids
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Large Neutral Amino Acid Transporter 1 (LAT1).